TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VEEV

Veeva Systems Inc Class A

Healthcare · Health Information Services

274.80$ +1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Veeva Systems Inc Class A (VEEV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 9,060 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VEEV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
788 918 996 1,036 1,046 1,200 1,318 1,365 1,397 1,654 1,776 1,860 1,900 2,272 2,405 2,516 2,584 3,046 3,222 3,351 3,367 3,816 4,011 4,117 4,183 4,804 5,023 5,228 5,226 5,911 6,188 6,331 6,453 7,340 7,765 7,999 8,097 8,979 9,130 9,060
590 712 789 833 846 1,008 1,103 1,152 1,183 1,433 1,538 1,621 1,658 1,531 1,675 1,785 1,853 2,311 2,495 2,632 2,660 3,107 3,275 3,356 3,386 3,969 4,188 4,362 4,336 5,003 5,245 5,368 5,447 6,309 6,708 6,995 7,112 7,998 8,063 7,946
206 218 366 409 311 320 460 512 468 551 748 827 893 477 721 796 634 731 1,185 1,065 1,150 1,138 1,240 1,140 865 886 1,094 743 744 703 1,197 1,166 1,045 1,119 1,965 1,930 1,660 1,421 1,897 1,812
511 519 664 725 758 762 918 1,010 1,052 1,090 1,330 1,432 1,495 1,087 1,381 1,495 1,590 1,664 2,150 2,264 2,351 2,376 2,839 2,919 3,023 3,103 3,615 3,869 3,942 4,028 4,765 4,885 5,063 5,150 6,068 6,404 6,637 6,561 7,313 7,243
66 183 113 97 76 234 172 127 110 322 187 167 148 423 273 257 237 612 314 335 279 694 392 391 325 785 451 417 300 889 401 404 301 1,057 541 472 372 1,310 628 566
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – 0.0 0.0 – 0.0 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – –
48 50 52 54 53 52 52 51 54 55 55 73 77 55 53 104 54 111 52 106 104 104 103 111 108 105 50 57 106 – – – – – – – – – – –
96 96 96 96 96 96 96 96 96 96 96 96 96 439 439 439 436 436 436 437 437 440 440 440 440 440 440 440 440 440 440 440 440 440 440 440 440 440 488 493
41 39 37 35 33 31 30 28 26 25 23 21 20 135 129 124 119 115 110 107 103 102 97 92 87 82 78 73 68 63 58 53 49 44 41 36 33 30 56 56
183 265 287 269 228 329 343 314 259 416 441 415 342 606 604 560 477 780 777 731 598 905 943 873 764 1,088 1,080 1,076 846 1,266 1,298 1,146 951 1,507 1,554 1,361 1,057 1,765 1,825 1,629
168 247 269 256 214 315 326 295 237 401 413 383 307 551 550 501 417 716 710 663 537 841 879 799 690 1,007 1,006 1,002 768 1,179 1,223 1,070 857 1,398 1,457 1,255 945 1,637 1,702 1,456
6.3 5.2 2.7 3.9 10 5.1 1.9 4.2 5.3 6.9 5.8 6.7 7.4 10 10 11 11 12 11 11 11 11 12 11 12 11 11 11 9.6 9.3 10 10 9.2 10.0 11 11 11 12 13 15
5.0 5.7 5.2 6.3 7.4 6.9 9.0 7.7 11 9.1 8.4 8.6 9.9 19 15 16 21 23 19 21 26 20 25 31 41 42 44 50 36 32 32 28 32 30 37 34 33 38 41 36
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
606 653 709 767 818 872 974 1,050 1,138 1,238 1,335 1,445 1,559 1,666 1,801 1,957 2,106 2,266 2,445 2,620 2,769 2,912 3,068 3,244 3,419 3,716 3,943 4,153 4,380 4,645 4,889 5,185 5,501 5,832 6,211 6,639 7,041 7,215 7,304 7,431
190 212 247 287 321 355 434 484 548 619 692 771 853 920 1,006 1,100 1,197 1,300 1,415 1,524 1,630 1,727 1,827 1,918 2,026 2,215 2,346 2,458 2,593 2,740 2,902 3,073 3,259 3,455 3,683 3,883 4,119 4,364 4,624 4,898
147 148 151 154 154 154 155 155 156 157 158 159 159 159 159 186 162 162 162 163 163 163 162 162 162 162 163 163 164 164 164 165 165 166 166 167 168 168 166 165

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?